This inventor holds 1 USPTO granted patent and 5 published patent applications and 2 EPO patents. Top assignee: Flare Therapeutics Inc.. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023
Title: James E Audia: Innovator in PPARG Inverse Agonists
Introduction
James E Audia is a notable inventor based in Chicago, IL (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target PPARG. His work is essential for advancing treatments for various medical conditions.
Latest Patents
James E Audia holds a patent for "PPARG inverse agonists and uses thereof." This patent includes compounds of Formula (I) and pharmaceutically acceptable salts and compositions that are useful for treating a variety of conditions associated with PPARG. He has 1 patent to his name, showcasing his innovative approach to drug development.
Career Highlights
Audia is currently associated with Flare Therapeutics Inc., where he continues to push the boundaries of pharmaceutical research. His expertise in the field has positioned him as a key player in the development of new therapeutic agents.
Collaborations
Throughout his career, James E Audia has collaborated with talented individuals such as Jonathan E Wilson and Jacob I Stuckey. These partnerships have fostered an environment of innovation and creativity, leading to advancements in their shared field.
Conclusion
James E Audia's contributions to the field of pharmaceuticals, particularly through his patent on PPARG inverse agonists, highlight his role as an influential inventor. His work continues to pave the way for new treatments and innovations in medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile